Authors:
Avinash Singh, Amit Patil
Download free PDF
Cold Chain Logistics Equipment Market Size & Share 2026-2035
Report ID: GMI14961
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Cold Chain Logistics Equipment Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Cold Chain Logistics Equipment Market Size
The cold chain logistics equipment market was valued at USD 24.9 billion in 2025 and is projected to reach USD 27.2 billion in 2026, advancing at a 7.4% CAGR (2026–2035) to reach USD 51.8 billion by 2035. The market covers refrigerated storage and transport equipment, monitoring and control hardware, and temperature-controlled packaging used to preserve specified temperature conditions in food, pharmaceutical, healthcare, and chemical supply chains.
Cold Chain Logistics Equipment Market Key Takeaways
Market Leader: Trane Technologies led with over 15.5% market share in 2025.
Leading Players: Top 5 players in this market include Trane Technologies, Carrier Global Corporation, Daikin Industries, GEA Group, Liebherr Group, which collectively held a market share of 43.5% in 2025.
The market's expansion reflects two concurrent investment cycles. Mature logistics networks are replacing or upgrading installed equipment to meet refrigerant, energy-efficiency, traceability, and product-validation requirements, while developing markets are adding foundational storage and distribution capacity. Procurement is consequently shifting toward equipment that combines thermal performance with documented monitoring, controls, and compliance capability.
GMI Analyst View
Based on our primary research conversations with cold chain equipment procurement leaders and regional logistics directors across food processing and pharmaceutical end-use sectors, the global cold chain logistics equipment market is tracking toward USD 37.2 billion by 2030. We see that midpoint as evidence that pharmaceutical supply-chain upgrades and food-safety digitisation can sustain market momentum even as refrigerant-transition costs constrain portions of European investment.
Cold Chain Logistics Equipment Market Trends, Growth Drivers & GMI Forecast Outlook
Cold chain equipment demand is becoming more specification-led as pharmaceutical supply chains require validated performance, food operators face traceability obligations, and refrigeration fleets adapt to lower-emission technologies. These requirements support higher-value equipment replacement and retrofit activity, even where capital budgets remain selective.
Key Drivers
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Public support for refrigerated infrastructure can convert otherwise fragmented farm-to-market investment into bankable equipment projects. In India, the PMKSY framework links storage, pre-cooling, distribution, and transport needs, creating opportunities for suppliers that can support multi-stage project execution rather than sell isolated refrigeration assets. The resulting demand is particularly relevant to modular systems and transport equipment that can be deployed as networks expand. [1]Press Information Bureau, Government of India. “Cabinet Approves Additional Outlay for PMKSY.” pib.gov.in
Pharmaceutical procurement follows a different mechanism. Biologics, mRNA products, and cell and gene therapies require qualified temperature control, documented handoffs, and equipment capable of maintaining integrity at demanding setpoints. This favors suppliers able to integrate ultra-cold storage, specialized packaging, and monitoring hardware into validated operating workflows. World Health Organization guidance on vaccine and biologics cold-chain management reinforces the importance of reliable temperature control and equipment qualification in these applications. [5]World Health Organization. “WHO Technical Report — Cold Chain and Vaccine Management.” who.int
Traceability requirements also create an installed-base opportunity. Food and pharmaceutical operators cannot rely solely on periodic manual checks where regulatory compliance and product release depend on complete temperature records. Networked data loggers, alarms, and control hardware can therefore be added during maintenance, fleet renewal, or facility modernization projects, broadening demand beyond greenfield capacity additions. [2]U.S. Food and Drug Administration. “FSMA Final Rule on Requirements for Additional Traceability Records for Certain Foods.” fda.gov[3]European Medicines Agency. “Guideline on Good Distribution Practice of Medicinal Products for Human Use.” ema.europa.eu
Key Restraints
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
The European refrigerant transition is changing the timing and composition of capital expenditure. Operators facing tighter HFC rules may replace equipment ahead of its preferred commercial cycle, directing budgets toward compliant technology rather than capacity enlargement. For manufacturers, the opportunity is real but operationally demanding: equipment design, service capability, technician training, and refrigerant availability must align with the transition timetable. [4]European Environment Agency. “Hydrofluorocarbon Phase Out in Europe.” eea.europa.eu
Food and beverage remains indispensable to global equipment demand, but mature retail, processing, and distribution networks limit its incremental intensity in developed markets. Faster-growing pharmaceutical, healthcare, and outsourced-logistics demand must therefore carry a larger share of the market's mix improvement. This creates a premium on portfolios that serve both high-volume food logistics and high-specification healthcare applications.
Capital intensity remains a persistent obstacle in markets where cold storage projects require simultaneous investment in insulation, refrigeration systems, electrical resilience, monitoring, and operational validation. Operators may choose narrower temperature capability or delay projects when financing is unavailable, constraining the pace at which informal or partially developed supply chains become fully temperature controlled.
GMI Analyst View
We see the market moving from capacity-led purchasing toward procurement decisions centered on compliance-ready performance. Suppliers that can combine refrigeration hardware, monitoring, and validation support should be better positioned than vendors competing principally on equipment volume or upfront price.
Cold Chain Logistics Equipment Market Segment Analysis
By Equipment Type
Storage Equipment generated USD 8.70 billion in 2025 and is expected to represent 32.9% of the market in 2035. Storage remains the physical anchor of the cold chain logistics equipment market because food distribution, pharmaceutical manufacturing, and third-party logistics facilities require fixed refrigerated capacity. Its relative mix position is likely to ease as monitoring and packaging capture more procurement value, but replacement demand tied to energy efficiency, automation, and refrigerant transitions supports continued investment.
Transportation Equipment is projected to reach USD 16.8 billion by 2035, after accounting for 34.9% of market revenue in 2025. Transport refrigeration demand is supported by dispersed food distribution, reefer-container movement, and growing temperature-controlled last-mile delivery. The category is also exposed to refrigerant rules and operating-cost scrutiny, making fleet replacement decisions increasingly dependent on lifecycle economics and compliance readiness.
Monitoring & Control Systems generated USD 2.0 billion in 2025 and are forecast to grow at a 9.7% CAGR (2026–2035). This category benefits from a retrofit pathway not available to many capital-intensive refrigeration assets. Operators can add monitoring, alerting, and data-capture capabilities to existing facilities and fleets, making the segment resilient where new-build investment is delayed but auditability requirements continue to tighten.
Temperature-Controlled Packaging is expected to reach USD 12.7 billion by 2035 and represented 22.3% of the market in 2025. Packaging is gaining importance as pharmaceutical distribution moves toward direct-to-patient, clinical, and decentralized delivery models. Demand is especially favorable for validated reusable and single-use solutions that protect product integrity while simplifying handling across fragmented logistics networks.
By Temperature Range
Ultra-Cold/Deep Frozen equipment generated USD 3.1 billion in 2025 and is projected to expand at a 9.9% CAGR (2026–2035). The segment is increasingly linked to advanced therapeutics rather than being confined to a narrow vaccine niche. Biologics and cell- and gene-therapy distribution require specialized storage, shipping, monitoring, and qualification practices, raising both equipment complexity and the commercial consequences of temperature excursions. [5]World Health Organization. “WHO Technical Report — Cold Chain and Vaccine Management.” who.int
Frozen equipment is expected to reach USD 13.7 billion by 2035 and accounted for 27.8% of market revenue in 2025. Frozen-food trade provides the category with a broad, recurring demand base across storage, transport, and retail handling. Pharmaceutical intermediates add a specialized layer of demand, although food logistics remains the principal source of equipment volume.
Chilled/Fresh equipment generated USD 8.2 billion in 2025 and is expected to represent 31.6% of the market in 2035. Fresh produce, dairy, meat, seafood, prepared food, and conventional pharmaceutical products make chilled applications central to the market's installed base. The broad set of use cases favors versatile equipment configurations and makes operating reliability particularly important across high-throughput supply chains.
Cool/Ambient Chilled equipment is forecast to reach USD 7.2 billion by 2035 and represented 14.9% of the market in 2025. This range serves specialty food and selected pharmaceutical products that require managed conditions without deep refrigeration. Suppliers benefit when customers seek differentiated temperature control while avoiding the energy and infrastructure burden of colder storage environments.
Controlled Room Temperature equipment accounted for 11.9% of the market in 2025 and is projected to grow at a 7.6% CAGR (2026–2035). Controlled-room-temperature demand is supported by specialty medicines and distribution models that require assured product integrity without conventional refrigeration. Active packaging and monitoring are important differentiators because they allow operators to manage risk across complex, multi-node delivery paths.
By Application
Food & Beverage generated USD 11.0 billion in 2025 and is expected to account for 39.6% of the market in 2035. The application remains the largest source of cold chain logistics equipment market demand because it spans food processing, retail, foodservice, exports, and distribution. Its growth profile is comparatively measured, however, because much of the installed infrastructure in developed markets is mature and procurement increasingly centers on replacement, efficiency, and compliance upgrades.
Pharmaceuticals & Biopharma represented 23.5% of the market in 2025 and are projected to reach USD 14.7 billion by 2035. This application is reshaping the market's value mix through demand for qualified ultra-cold equipment, specialized transport solutions, and continuous monitoring. The technical requirements associated with biologics and advanced therapies favor suppliers that can demonstrate validated thermal performance and documentation discipline. [5]World Health Organization. “WHO Technical Report — Cold Chain and Vaccine Management.” who.int
Healthcare & Clinical applications are expected to reach USD 6.1 billion by 2035 and are forecast to grow at a 9.0% CAGR (2026–2035). Hospitals, clinical networks, and diagnostic settings increasingly require temperature-controlled capacity for blood products, advanced therapeutics, and point-of-care applications. Investment is moving beyond specialized pharmaceutical logistics into more distributed care environments, widening the addressable equipment base.
Chemicals & Agrochemicals generated USD 2.8 billion in 2025 and are projected to grow at a 6.1% CAGR (2026–2035). Demand in this application is shaped by specialty materials, regulated storage, and selected temperature-sensitive inputs. Compared with pharmaceutical demand, purchasing is more closely tied to industrial investment cycles and less directly supported by clinical pipeline complexity or stringent patient-safety requirements.
By End-User
Food & Beverage Manufacturers & Processors generated USD 6.6 billion in 2025 and are expected to account for 23.3% of end-user demand in 2035. This cohort continues to invest in throughput, product quality, and food-loss reduction, but its procurement pattern varies sharply by geography. Mature facilities prioritize operational upgrades, while emerging-market processors require foundational refrigeration and handling capacity to serve modern retail and export channels.
Food Retailers & Distributors are projected to reach USD 8.3 billion by 2035 and represented 18.0% of end-user demand in 2025. Retail and distribution operators must balance energy consumption, store or warehouse productivity, product availability, and food-safety assurance. Their purchasing increasingly favors equipment that can be monitored centrally and maintained predictably across geographically dispersed estates.
Pharmaceutical & Biopharma Companies generated USD 5.5 billion in 2025 and are projected to reach USD 13.5 billion by 2035. This end-user group requires equipment that supports product release, auditability, and risk mitigation across manufacturing and distribution. As therapy portfolios become more temperature sensitive, capital spending is likely to favor integrated solutions over isolated refrigeration components.
Healthcare Providers are projected to reach USD 5.2 billion by 2035 and are forecast to grow at an 8.5% CAGR (2026–2035). Healthcare-provider demand reflects the movement of advanced diagnostics and therapeutics closer to patient-care settings. Equipment needs are often constrained by limited footprint, strict operating procedures, and the need for staff to manage cold-chain risk without dedicated logistics teams.
Third-Party Logistics Providers are projected to reach USD 7.5 billion by 2035, up from USD 3.3 billion in 2025. 3PL providers are becoming increasingly important equipment buyers as manufacturers outsource specialized cold-chain execution. Their scale and multi-client operating models create demand for flexible assets, fleet management capability, and standardized monitoring across a range of customer specifications.
Chemical & Industrial Companies generated USD 1.9 billion in 2025 and are forecast to grow at a 5.8% CAGR (2026–2035). This cohort tends to emphasize durable, application-specific refrigeration infrastructure rather than rapid network expansion. Demand remains relevant for regulated and sensitive products, although it lacks the broad regulatory and product-pipeline tailwinds seen in pharmaceutical and healthcare end markets.
By Distribution Channel
Direct Sales represented 42.4% of the market in 2025 and are expected to grow at an 8.3% CAGR (2026–2035). Direct engagement remains essential where equipment must be engineered around facility design, validation requirements, or custom operating conditions. Manufacturers can use these relationships to bundle monitoring, maintenance, and documentation support with high-value refrigeration systems.
Indirect Sales accounted for 57.6% of the market in 2025 and are expected to represent 54.2% in 2035. Distributors, dealers, integrators, marketplaces, and rental providers remain important for broad geographic coverage and localized service. Their share moderation reflects the migration of certain standardized products toward direct digital purchasing rather than a wholesale displacement of channel partners.
OEM Direct / Manufacturer Sales Force generated USD 6.9 billion in 2025 and is expected to account for 25.2% of the market in 2035. Complex cold rooms, refrigerated transport configurations, and pharmaceutical-grade installations still require direct technical consultation. This channel retains strategic importance where engineering accountability and compliance documentation cannot be readily standardized.
Manufacturer E-Commerce & Digital Platforms are forecast to grow at an 11.6% CAGR (2026–2035) and are expected to reach USD 10.7 billion by 2035. Digital platforms shorten procurement cycles for repeatable configurations and create opportunities to cross-sell monitoring devices, packaging, and accessories. Their value proposition is strongest where specifications are sufficiently clear for buyers to compare products without extensive application engineering.
Authorized Distributors & Dealers generated USD 7.9 billion in 2025 and are projected to grow at a 5.6% CAGR (2026–2035). The channel remains valuable for installation support, local service, and market access, especially in fragmented customer bases. It faces pressure where large buyers establish direct OEM relationships or where routine equipment becomes easier to source online.
Online Marketplaces are forecast to grow at a 12.1% CAGR (2026–2035) and represented 5.7% of the market in 2025. Marketplace adoption is most relevant to standardized packaging, data loggers, and smaller monitoring products. These channels are less suited to projects that require site-specific refrigeration design, installation coordination, or regulatory qualification.
Rental & Leasing Companies generated USD 1.4 billion in 2025 and are forecast to grow at a 9.5% CAGR (2026–2035). Leasing offers customers a way to preserve capital flexibility during clinical trials, seasonal peaks, and temporary capacity requirements. The model is particularly attractive where demand uncertainty makes permanent ownership less compelling than access to qualified equipment.
GMI Analyst View
We interpret the segment mix as a bifurcation between high-volume infrastructure and higher-specification equipment. Traditional refrigeration will remain central, but suppliers with credible monitoring, packaging, ultra-cold, and validation capabilities should capture a growing share of the most defensible procurement opportunities.
Cold Chain Logistics Equipment Market Regional Analysis
North America Cold Chain Logistics Equipment Market Analysis
North America generated USD 8.0 billion in 2025 and is projected to reach USD 14.8 billion by 2035. The cold chain logistics equipment market in North America is characterized by a mature installed base and procurement centered on technology upgrades. Food traceability, pharmaceutical distribution requirements, natural-refrigerant adoption, and the need to modernize aging facilities support demand for monitoring-integrated systems and specialized cold capacity. [2]U.S. Food and Drug Administration. “FSMA Final Rule on Requirements for Additional Traceability Records for Certain Foods.” fda.gov
United States
The United States is projected to reach USD 10.5 billion by 2035, from USD 5.7 billion in 2025. U.S. demand is supported by extensive food distribution and pharmaceutical logistics networks. Food traceability requirements encourage monitoring upgrades, while biologics manufacturing and clinical distribution sustain demand for qualified storage, transport, and data-capture equipment. [2]U.S. Food and Drug Administration. “FSMA Final Rule on Requirements for Additional Traceability Records for Certain Foods.” fda.gov
Canada
Canada benefits from close integration with U.S. food trade and pharmaceutical distribution. Demand is concentrated in food processing, cross-border refrigerated transport, and equipment modernization aligned with established food-safety and pharmaceutical-quality practices.
Europe Cold Chain Logistics Equipment Market Analysis
Europe generated USD 6.0 billion in 2025 and is forecast to grow at a 5.9% CAGR (2026–2035). The cold chain logistics equipment market in Europe combines substantial installed infrastructure with a demanding refrigerant-transition agenda. Compliance expenditures support replacement activity, but they can also defer discretionary capacity additions when operators prioritize conversion of existing assets. [4]European Environment Agency. “Hydrofluorocarbon Phase Out in Europe.” eea.europa.eu
Germany
Germany generated USD 1.3 billion in 2025 and is projected to reach USD 2.4 billion by 2035. Germany's pharmaceutical production base, food-export infrastructure, and engineering capabilities sustain demand for industrial refrigeration and validated cold-chain equipment. F-Gas compliance further supports procurement of alternative-refrigerant systems and associated controls. [4]European Environment Agency. “Hydrofluorocarbon Phase Out in Europe.” eea.europa.eu
United Kingdom
The United Kingdom's demand is anchored in grocery distribution and life-sciences logistics. Equipment procurement increasingly emphasizes continuous visibility, storage reliability, and documentation across pharmaceutical distribution operations. [3]European Medicines Agency. “Guideline on Good Distribution Practice of Medicinal Products for Human Use.” ema.europa.eu
France
France benefits from fresh-food retail, agricultural supply chains, and pharmaceutical distribution. Equipment investment is shaped by the need to preserve quality across complex domestic and export-oriented logistics flows.
Italy
Italy's food-processing and fresh-produce export sectors support ongoing refrigeration and transport-equipment demand. Pharmaceutical logistics provides a complementary source of investment in monitored and validated cold-chain systems.
Rest of Europe
The rest of Europe encompasses markets with varying infrastructure maturity and regulatory readiness. Across these markets, compliance with distribution standards and the refrigerant transition are reinforcing interest in efficient, serviceable, and digitally monitored equipment. [3]European Medicines Agency. “Guideline on Good Distribution Practice of Medicinal Products for Human Use.” ema.europa.eu[4]European Environment Agency. “Hydrofluorocarbon Phase Out in Europe.” eea.europa.eu
Asia Pacific Cold Chain Logistics Equipment Market Analysis
Asia Pacific is projected to reach USD 17.7 billion by 2035 and represented 28.8% of global market revenue in 2025. The cold chain logistics equipment market in Asia Pacific is driven by a combination of primary infrastructure formation and advanced-system upgrading. Large markets are expanding refrigerated networks for food and pharmaceutical logistics, while more mature economies focus on precision monitoring, energy efficiency, and high-value pharmaceutical applications.
China
China generated USD 3.7 billion in 2025 and is projected to reach USD 9.0 billion by 2035. China's scale in food processing, urban distribution, e-commerce, and pharmaceutical manufacturing makes it a principal driver of regional equipment demand. Growth is supported by the need to extend refrigerated networks while increasing their reliability, monitoring coverage, and suitability for higher-value healthcare products.
India
India generated USD 0.90 billion in 2025 and is forecast to grow at a 12.1% CAGR (2026–2035). India's growth reflects a substantial need for pre-cooling, multi-temperature storage, distribution hubs, and refrigerated transport. Government-backed cold-chain programs can lower barriers to private investment, while food processing and formalized pharmaceutical distribution expand the potential equipment base. [1]Press Information Bureau, Government of India. “Cabinet Approves Additional Outlay for PMKSY.” pib.gov.in
Japan
Japan is a mature market in which procurement centers on precision equipment, energy performance, pharmaceutical-grade storage, and advanced monitoring. Demand is more replacement-led than network-formation-led, favoring high-reliability solutions.
Australia
Australia's meat, dairy, and export-oriented food industries sustain demand for refrigerated storage and transport. Pharmaceutical distribution and clinical logistics also support adoption of monitored passive packaging and specialized temperature-control systems.
Rest of Asia Pacific
The rest of Asia Pacific includes markets at differing stages of cold-chain development. Rising modern retail, food processing, healthcare access, and pharmaceutical manufacturing create a broad investment runway, although financing conditions and grid reliability remain material constraints in some locations.
Latin America Cold Chain Logistics Equipment Market Analysis
Latin America is projected to reach USD 5.1 billion by 2035 and is forecast to grow at an 8.7% CAGR (2026–2035). The cold chain logistics equipment market in Latin America has an intermediate level of infrastructure development: major urban centers and export corridors are relatively established, while secondary cities and agricultural supply chains retain significant capacity gaps. This supports a mix of network expansion, food-export investment, and pharmaceutical logistics modernization.
Brazil
Brazil is projected to reach USD 2.6 billion by 2035 and accounted for 52.0% of Latin American market revenue in 2025. Brazil's food-export economy requires large-scale refrigerated storage and transport across domestic production areas, ports, and distribution nodes. Its developing pharmaceutical and biopharma ecosystem adds demand for temperature-validated equipment beyond traditional food logistics.
Mexico
Mexico benefits from deep integration with North American food supply chains. Fresh produce, processed food, and cross-border trade sustain transport and storage demand, while domestic pharmaceutical manufacturing adds a need for higher-specification cold-chain systems.
Rest of Latin America
The rest of Latin America presents uneven infrastructure maturity but a meaningful need for cold-chain formalization. Suppliers that can adapt equipment to local financing, energy, and service conditions are better positioned to address latent demand.
Middle East & Africa Cold Chain Logistics Equipment Market Analysis
Middle East & Africa generated USD 1.5 billion in 2025 and is forecast to grow at a 7.6% CAGR (2026–2035). The cold chain logistics equipment market in the Middle East & Africa is shaped by high ambient temperatures, food-import dependence in Gulf markets, and the gradual formalization of pharmaceutical distribution. Refrigeration is often a core logistics requirement rather than a premium service, but project economics depend heavily on power reliability, financing, and operating capability.
UAE
The UAE generated USD 0.50 billion in 2025 and is forecast to grow at a 9.2% CAGR (2026–2035). The UAE's logistics-hub model supports demand for cold storage, transport, and monitoring equipment tied to import, re-export, pharmaceutical, and perishable-cargo flows. Port-linked infrastructure and the need for reliable performance in extreme temperatures reinforce investment in high-capacity, controlled systems.
Saudi Arabia
Saudi Arabia's demand is supported by food-security initiatives, domestic food-processing investment, and the growth of pharmaceutical manufacturing and distribution. The market offers opportunities for suppliers able to support large projects and meet increasingly formalized quality requirements.
Rest of Middle East & Africa
The rest of Middle East & Africa includes both established logistics nodes and underdeveloped cold-chain markets. Equipment adoption depends on urbanization, food-distribution investment, health-system development, and the availability of financing for capital-intensive projects.
GMI Analyst View
We view Asia Pacific's outperformance as a portfolio of staggered investment cycles rather than a single regional trend. Infrastructure build-out, food-system modernization, and pharmaceutical capacity expansion are occurring at different speeds, which should help sustain demand even as individual national programs mature.
Cold Chain Logistics Equipment Market Share & Competitive Landscape
The cold chain logistics equipment market share structure is moderately concentrated: the five leading companies collectively held approximately 43.5% of global revenue in 2025. The remaining market is distributed across regional refrigeration specialists, packaging providers, monitoring vendors, and manufacturers serving country-specific operating and regulatory requirements.
Trane Technologies, through Thermo King, held a 15.5% market share in 2025. Its position is supported by transport refrigeration expertise, a broad installed base, and the ability to connect fleet equipment with monitoring and aftermarket support.
Carrier Global Corporation held a 15.1% market share in 2025. Carrier competes across transport refrigeration and storage-oriented systems, giving it exposure to trailer, container, and facility applications in multiple geographies.
Daikin Industries held a 6.3% market share in 2025. Its refrigeration systems portfolio and established presence across Asia Pacific support participation in cold storage projects, food processing, and regional distribution expansion.
GEA Group and Liebherr Group maintain meaningful positions in industrial refrigeration and specialized cold-chain equipment, particularly in Europe and food-processing environments. Their competitive relevance stems from engineering capability, application knowledge, and access to customers requiring complex facility systems.
Dover Corporation, Johnson Controls International, CIMC, Hoshizaki Corporation, Hussmann Corporation, PHC Holdings Corporation, Epta, Frigoglass Group, Haier Biomedical, Schmitz Cargobull, CSafe Global, Cold Chain Technologies, Pelican Products, ThermoSafe, Wabash National, and Elitech Technology address distinct niches across retail refrigeration, reefers, biomedical storage, thermal packaging, trailers, and monitoring. Competitive advantage increasingly depends on service reach, regulatory qualification, energy performance, digital connectivity, and the ability to support customers across storage, transport, and packaging requirements.
Recent Industry Developments
Peli BioThermal Acquires Evo Cryogenic Shipper Portfolio from BioLife Solutions (October 2025)
Peli BioThermal announced the acquisition of BioLife Solutions' Evo cryogenic shipper portfolio and integrated monitoring platform in October 2025. The transaction expands Peli BioThermal's capability in cryogenic cell- and gene-therapy transport and reflects growing industry emphasis on pairing specialized thermal hardware with digital visibility. [6]Peli BioThermal. “Peli BioThermal Announces Acquisition of Evo from BioLife Solutions.” prnewswire.com
Cold Chain Technologies Acquires Global Cold Chain Solutions, Expanding Asia Pacific Presence (March 2025)
Cold Chain Technologies announced its acquisition of Global Cold Chain Solutions in March 2025, extending its presence in Australia and India. The transaction strengthens its passive thermal packaging and assurance capabilities in Asia Pacific, where pharmaceutical and life-sciences supply chains are expanding. [7]Cold Chain Technologies. “Cold Chain Technologies Acquires Global Cold Chain Solutions.” morningstar.com
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →